Stock FATE FATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Fate Therapeutics, Inc.

Equities

FATE

US31189P1021

Real-time Estimate Cboe BZX
Other stock markets
 09:53:14 2024-05-14 am EDT 		5-day change 1st Jan Change
4.215 USD +1.57% Intraday chart for Fate Therapeutics, Inc. +11.08% +15.24%
May. 10 Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating MT
May. 10 Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. FATE Stock
  4. News Fate Therapeutics, Inc.
  5. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW